• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏肌球蛋白结合蛋白 C 中意义不确定变体致病性评估中的蛋白质热力学不稳定性。

Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C.

机构信息

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Federico II, Naples, Italy.

出版信息

J Cardiovasc Transl Res. 2020 Oct;13(5):867-877. doi: 10.1007/s12265-020-09959-6. Epub 2020 Feb 7.

DOI:10.1007/s12265-020-09959-6
PMID:32034629
Abstract

In the era of next generation sequencing (NGS), genetic testing for inherited disorders identifies an ever-increasing number of variants whose pathogenicity remains unclear. These variants of uncertain significance (VUS) limit the reach of genetic testing in clinical practice. The VUS for hypertrophic cardiomyopathy (HCM), the most common familial heart disease, constitute over 60% of entries for missense variants shown in ClinVar database. We have studied a novel VUS (c.1809T>G-p.I603M) in the most frequently mutated gene in HCM, MYBPC3, which codes for cardiac myosin-binding protein C (cMyBPC). Our determinations of pathogenicity integrate bioinformatics evaluation and functional studies of RNA splicing and protein thermodynamic stability. In silico prediction and mRNA analysis indicated no alteration of RNA splicing induced by the variant. At the protein level, the p.I603M mutation maps to the C4 domain of cMyBPC. Although the mutation does not perturb much the overall structure of the C4 domain, the stability of C4 I603M is severely compromised as detected by circular dichroism and differential scanning calorimetry experiments. Taking into account the highly destabilizing effect of the mutation in the structure of C4, we propose reclassification of variant p.I603M as likely pathogenic. Looking into the future, the workflow described here can be used to refine the assignment of pathogenicity of variants of uncertain significance in MYBPC3.

摘要

在下一代测序(NGS)时代,遗传性疾病的基因检测鉴定出越来越多的致病性仍不清楚的变体。这些意义不明的变体(VUS)限制了基因检测在临床实践中的应用。肥厚型心肌病(HCM)是最常见的家族性心脏病,其 VUS 占 ClinVar 数据库中显示的错义变体条目超过 60%。我们研究了一种新型 VUS(c.1809T>G-p.I603M),该变体位于 HCM 中最常突变的基因 MYBPC3 中,该基因编码心肌肌球蛋白结合蛋白 C(cMyBPC)。我们对致病性的确定综合了生物信息学评估和 RNA 剪接以及蛋白质热力学稳定性的功能研究。计算机预测和 mRNA 分析表明,该变体未引起 RNA 剪接的改变。在蛋白质水平上,p.I603M 突变位于 cMyBPC 的 C4 结构域。尽管该突变不会使 C4 结构域的整体结构发生很大变化,但圆二色性和差示扫描量热法实验表明 C4 I603M 的稳定性严重受损。考虑到突变对 C4 结构的高度不稳定作用,我们建议将变体 p.I603M 重新归类为可能的致病性。展望未来,这里描述的工作流程可用于细化 MYBPC3 中意义不明变体致病性的分配。

相似文献

1
Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C.心脏肌球蛋白结合蛋白 C 中意义不确定变体致病性评估中的蛋白质热力学不稳定性。
J Cardiovasc Transl Res. 2020 Oct;13(5):867-877. doi: 10.1007/s12265-020-09959-6. Epub 2020 Feb 7.
2
Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.检测到肥厚型心肌病病例中肌球蛋白结合蛋白 C3 基因的大片段重复突变。
Gene. 2013 Sep 15;527(1):416-20. doi: 10.1016/j.gene.2013.06.025. Epub 2013 Jun 29.
3
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation.利用 MYBPC3 中蛋白质亚结构域稳定性的计算预测,能够对肥厚型心肌病进行临床风险分层,并增强对变异的解读。
Genet Med. 2021 Jul;23(7):1281-1287. doi: 10.1038/s41436-021-01134-9. Epub 2021 Mar 29.
4
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.心血管磁共振成像显示,MYH7(β-肌球蛋白重链)相关与MYBPC3(肌球蛋白结合蛋白C)相关的肥厚型心肌病在表型上无差异。
Circ Cardiovasc Imaging. 2017 Feb;10(2). doi: 10.1161/CIRCIMAGING.116.005311.
5
Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.心脏肌球蛋白结合蛋白C基因的突变是芬兰东部家族性肥厚型心肌病的主要病因。
J Mol Med (Berl). 2002 Jul;80(7):412-22. doi: 10.1007/s00109-002-0323-9. Epub 2002 Apr 11.
6
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.蛋白杂合不足驱动子鉴定出导致肥厚型心肌病的 MYBPC3 变异体。
J Biol Chem. 2021 Jul;297(1):100854. doi: 10.1016/j.jbc.2021.100854. Epub 2021 Jun 5.
7
Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.肥厚型心肌病相关变体的心肌肌球蛋白结合蛋白 C3 显示出改变的分子特性和肌动蛋白相互作用。
Biochem J. 2018 Dec 14;475(24):3933-3948. doi: 10.1042/BCJ20180685.
8
Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.通过下一代测序检测的肌球蛋白结合蛋白C(MYBPC3)基因突变所致限制性心肌病的新型表型-基因型相关性
J Am Heart Assoc. 2015 Jul 10;4(7):e001879. doi: 10.1161/JAHA.115.001879.
9
A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.一种新的家族性小儿肥厚型心肌病的 TPM1 基因纯合突变及潜在靶向药物的计算机筛选
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7732-7744. doi: 10.26355/eurrev_202007_22299.
10
Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.通过使用Ion Torrent PGM系统的靶向测序方法,在遗传性心肌病患者中鉴定包括双突变在内的新型突变。
Int J Mol Med. 2016 Jun;37(6):1511-20. doi: 10.3892/ijmm.2016.2565. Epub 2016 Apr 14.

引用本文的文献

1
Bringing into focus the central domains C3-C6 of myosin binding protein C.聚焦肌球蛋白结合蛋白C的中心结构域C3-C6。
Front Physiol. 2024 Feb 29;15:1370539. doi: 10.3389/fphys.2024.1370539. eCollection 2024.
2
Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy.肥厚型心肌病中意义未明变异体特征描述的基础科学方法。
Front Cardiovasc Med. 2023 Aug 1;10:1238515. doi: 10.3389/fcvm.2023.1238515. eCollection 2023.
3
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.
肥厚型心肌病中 MYBPC3 基因突变的研究进展。
Int J Mol Sci. 2023 Jun 22;24(13):10510. doi: 10.3390/ijms241310510.
4
Contribution of Genetic Test to Early Diagnosis of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency: The Experience of a Reference Center in Southern Italy.遗传检测对亚甲基四氢叶酸还原酶(MTHFR)缺乏症早期诊断的贡献:意大利南部参考中心的经验。
Genes (Basel). 2023 Apr 26;14(5):980. doi: 10.3390/genes14050980.
5
Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes.遗传性心肌病和离子通道病的下一代测序基因Panel:罕见基因中的致病性变异和意义不明变异的流行率。
Biomolecules. 2022 Oct 3;12(10):1417. doi: 10.3390/biom12101417.
6
Molecular characterization of linker and loop-mediated structural modulation and hinge motion in the C4-C5 domains of cMyBPC.肌球蛋白结合蛋白 C (cMyBPC) C4-C5 结构域中连接区和环介导的结构调节及铰链运动的分子特征
J Struct Biol. 2022 Jun;214(2):107856. doi: 10.1016/j.jsb.2022.107856. Epub 2022 Apr 13.
7
Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation .评估肌球蛋白结合蛋白 C 结构域 C2 的热力学和力学不稳定性对致肥厚型心肌病双突变的发病机制的贡献。
Int J Mol Sci. 2021 Nov 4;22(21):11949. doi: 10.3390/ijms222111949.
8
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.蛋白杂合不足驱动子鉴定出导致肥厚型心肌病的 MYBPC3 变异体。
J Biol Chem. 2021 Jul;297(1):100854. doi: 10.1016/j.jbc.2021.100854. Epub 2021 Jun 5.
9
Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.线粒体心肌病的分子流行病学:线粒体和核基因的研究
Int J Mol Sci. 2021 May 27;22(11):5742. doi: 10.3390/ijms22115742.
10
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.心肌肌球蛋白结合蛋白 C 突变导致肥厚型心肌病的纳米力学表型。
ACS Nano. 2021 Jun 22;15(6):10203-10216. doi: 10.1021/acsnano.1c02242. Epub 2021 Jun 1.